Osstem Implant (오스템임플란트) raises stake in Hans Biomedical (한스바이오메드) to 12.48% following conversion price adjustment

stake_5pct · spotted Sep 3, 2026, 3:36 PM KST

• Osstem Implant filed a simplified large shareholding report (약식) on 2025-04-04 disclosing ownership of 1,415,354 shares, equal to 12.48% of Hans Biomedical (KRX: 042520, KOSDAQ).
• The reported stake increased by 58,373 shares (+0.44 percentage points) from the prior filing, attributed to a convertible bond conversion price adjustment and open-market buying and/or selling by a specially related party (특별관계자).
• No voting agreement or joint exercise of control (공동보유) figures were disclosed; the controlling stake fields are marked as not applicable.

The conversion price adjustment on the underlying convertible bond has mechanically increased Osstem Implant's share count without a market transaction, and any further downward adjustment to the conversion price could dilute existing shareholders further and raise Osstem Implant's percentage stake beyond 12.48%.

AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.